NYSE:ZBHMedical Equipment
Zimmer Biomet (ZBH) Valuation After Baird Downgrade and Shift to Hold-Consensus Analyst Sentiment
Baird’s downgrade of Zimmer Biomet Holdings (ZBH) to Neutral, along with lower targets from other brokers, has cooled near term enthusiasm, even as the company maintains its dividend and advances a new digital health partnership.
See our latest analysis for Zimmer Biomet Holdings.
Against that backdrop, Zimmer Biomet’s share price near $91.56 reflects a stock where momentum has faded, with a negative year to date share price return and weak multi year total shareholder returns despite solid...